{
  "ticker": "RGT",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02967107",
  "id": "02967107",
  "pages": 2,
  "price_sensitive": true,
  "date": "20250708",
  "time": "0926",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250708/pdf/06ll350bd54grs.pdf",
  "summary": "- **EU-GMP cannabinoid API supply commenced** to University Medical Centre Ljubljana (Slovenia) for epilepsy treatment, transitioning from pilot to routine use.  \n- **Regulatory milestone**: Collaboration with Slovenian health authorities established framework for hospital compounding of cannabinoid formulations.  \n- **Strategic impact**: Validates Argent\u2019s ability to scale pilot programs, reinforcing EU market expansion for cannabinoid therapies.  \n\n*No capital markets or trading-specific information (e.g., raises, halts, financials) identified.*",
  "usage": {
    "prompt_tokens": 1514,
    "completion_tokens": 107,
    "total_tokens": 1621,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-07T23:43:02.939467"
}